Evaluate the Effect of Dietary Supplement Combined Exercise Among Patients With Sarcopenia Comorbid With Lung Disease
Recruiting · NCT05926713 · Interventional (participants receive a specific treatment) · Lead sponsor: Orient Europharma Co., Ltd.
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This trial is a prospective multi-center study. The purpose of this study is to evaluate the effect of dietary supplement combined with supervised exercised on the physical performance, body composition and lung function among patients with Sarcopenia and severe Sarcopenia in chronic lung disease. After participants enroll in this study, 12-week clinical trial will be conducted to analyze the improvement regarding Sarcopenia and different severity of Sarcopenia before and after the intervention of exercise and nutritional products, which can further provide reference for clinical intervention and rehabilitation.
Who can take part
Inclusion criteria
- Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from Department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment.
- Outpatients who meet the diagnostic criteria for Sarcopenia after evaluation by a physician.
Exclusion criteria
- Patients who refuse to sign the consent form
- Patients who are under 20 years old
- Patients who are bedridden or unable to walk due to physical disabilities
- Patients with terminal cancer or human-acquired immunodeficiency syndrome
- Patients with edema (grading pitting edema +2)
Where it is running
1 location listed.
- Taichung Veterans General Hospital - Taichung, Taiwan